Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01373073 · ClinicalTrials.gov registry record · Phase 3
Evaluation of a Novel Human Milk Fortifier in Preterm Infants
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 147
- Enrollment target
NCT01373073: Completed Phase 3 study, sponsored by Abbott Nutrition.
NCT01373073 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 147 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01373073, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 147 participants
- Enrollment target
Study Summary
The purpose of this study is to assess growth of preterm infants fed human milk supplemented with an experimental human milk fortifier.
Interventions
- OTHER Experimental human milk fortifier
- OTHER Control human milk fortifier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
What the finished NCT01373073 record still lists
NCT01373073 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental human milk fortifier is the first listed.
NCT01373073 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01373073 about?
NCT01373073 is a clinical study titled "Evaluation of a Novel Human Milk Fortifier in Preterm Infants". The purpose of this study is to assess growth of preterm infants fed human milk supplemented with an experimental human milk fortifier.
What is the current status of trial NCT01373073?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 147 participants. The study started on 2011-08. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01373073?
The interventions under investigation include: Experimental human milk fortifier (OTHER), Control human milk fortifier (OTHER).
Who is sponsoring clinical trial NCT01373073?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01373073's enrollment target sits among peer trials
147 1550th of 2000 higher than 450 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia